MMED
What one share of MiniMed Group holds
Surgical and Medical Instruments and Apparatus
We are a scaled global medical technology company that develops, manufactures, and markets a comprehensive suite of solutions for the management of diabetes. Since our founding more than 40 years ago, we have pioneered groundbreaking innovation and served the needs of our customers across the globe in service of our mission to make every day a better day for people with diabetes.
MiniMed Group’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-07-31; the balance sheet is as of 2026-07-31.
| Sales | $12.22 |
|---|---|
| Profit | −$1.19 |
| Capex (buildings and equipment) | $0.80 |
| Free cash flow | −$1.20 |
| Cash and investments | $0.74 |
| Book value | $12.87 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2024 | $9.77 | −$0.44 | $0.59 | −$0.42 | — | — |
| 2025 | $10.74 | −$0.84 | $0.76 | −$0.21 | — | — |
| 2026 | $12.09 | −$1.30 | $0.87 | −$1.64 | — | $12.86 |